AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Arcutis Biotherapeutics, Inc.

$32.07 +$3.07 (+10.59%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$31.97
Day Range
$31.67$32.53
Year Range
$19.30$33.30
Market Cap
4.03B
AVG Volume
2.2M
Trailing/Forward PE
145.24/24.43
PEG ratio
-0.4
Dividend Yield
-
Next Earnings Date
2026-11-04
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARQT Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2463.98M
26 Q1415.62M
25 Q4376.07M
25 Q3317.93M
25 Q2263.46M
25 Q1212.82M
24 Q4196.54M
24 Q3138.71M
24 Q2132.06M
24 Q1106.39M
Net Income (USD) · TTM
-300M-200M-100M0100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARQT Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q228.52M
26 Q1-2.38M
25 Q4-16.14M
25 Q3-44.32M
25 Q2-93.27M
25 Q1-129.72M
24 Q4-140.04M
24 Q3-195.53M
24 Q2-198.76M
24 Q1-217.42M
Operating Income (USD) · TTM
-200M-100M0100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARQT Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q234.25M
26 Q13.21M
25 Q4-12.23M
25 Q3-38.25M
25 Q2-85.84M
25 Q1-121.3M
24 Q4-128.4M
24 Q3-181.93M
24 Q2-179.77M
24 Q1-196.46M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: ARQT

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 4 Nov 2026.

Arcutis Biotherapeutics, Inc.
ARQT
Stockpicker

Video analysis: ARQT

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ARQT

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.